Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Diakonhjemmet Hospital
Virtual Tribunal Monastery
Brigham and Women's Hospital
Universitätsklinikum Hamburg-Eppendorf
Universitaire Ziekenhuizen KU Leuven
Instituto Mexicano del Seguro Social